top of page
15 mars 2022
OmiCure's DNA and RNA NGS Tumor profiling tests now available in the Middle East.
Paris France, March 15th, 2022, OMICURE® SAS a leading European digital health company, has announced a partnership agreement to distribute the company’s molecular tumor profiling RNA and DNA assays, in the Middle East. OMICURE® has signed the distribution partnership agreement with EUGENE.
bottom of page